Marksans Pharma P/E Ratio

MARKSANS • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
21.07
Moderate Valuation
High - Growth expectations or overvalued

Current Valuation Metrics

P/E Ratio 21.07
Current Price ₹170.00
EPS (TTM) ₹8.40
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 15.12
Historical Range 3.55 - 38.27
Percentile 85.7%

Sector Context

Sector Average 47.68
Sector Median 25.75
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹7.96
Sept 2025 ₹2.17
Mar 2025 ₹2.00

Key P/E Ratio Insights for Marksans Pharma

  • Current PE is 39.4% above historical average
  • Trading at discount to sector average PE of 47.68

P/E Ratio Historical Trend for Marksans Pharma

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 38.27 7.96 ₹304.65 NSE High
2024 19.76 8.13 ₹160.65 NSE Moderate
2023 8.21 7.17 ₹58.85 NSE Low
2022 11.82 5.23 ₹61.80 NSE Low
2021 10.6 5.75 ₹60.95 NSE Low
2020 3.55 4.83 ₹17.15 NSE Low
2019 13.62 2.07 ₹28.20 NSE Low

Sector P/E Ratio Comparison

Comparing Marksans Pharma with other companies in Healthcare sector
Sector Average
47.68
Sector Median
25.75
Lowest P/E
0.83
Highest P/E
898.7
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.83 ₹31 Low
Murae Organisor MURAE 2.86 ₹41 Low
Ind Swift Laboratories INDSWFTLAB 4.53 ₹1,133 Low
Amwill Health Care AMWILL 5.67 ₹64 Low
Brooks Laboratories BROOKS 6.14 ₹157 Low
Medicamen Organics MEDIORG 6.4 ₹27 Low
Zenith Drugs ZENITHDRUG 6.83 ₹69 Low
Unichem Laboratories UNICHEMLAB 7.15 ₹2,100 Low
Galaxy Medicare GML 7.41 ₹26 Low
Vasundhara Rasayans VRL 9.35 ₹34 Low